Stock Research: Gilead

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Gilead

NasdaqGS:GILD US3755581036
89
  • Value
    42
  • Growth
    82
  • Safety
    Safety
    69
  • Combined
    86
  • Sentiment
    78
  • 360° View
    360° View
    89
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Gilead Sciences, Inc. is a biopharmaceutical company focused on medicines for life-threatening diseases. It operates in the biopharmaceutical industry, with marketed products including Biktarvy and others. The company operates in more than 35 countries worldwide. In the last fiscal year, the company had a market cap of $135,066 million, profits of $22,503 million, revenue of $28,754 million, and 17,600 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 89 (better than 89% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Gilead are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Gilead. The consolidated Value Rank has an attractive rank of 69, which means that the share price of Gilead is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 69% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 82, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 78. But the company’s financing is risky with a Safety rank of 42. This means 58% of comparable companies have a safer financing structure than Gilead. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
69 67 n/a n/a
Growth
82 63 n/a n/a
Safety
Safety
42 70 n/a n/a
Sentiment
78 98 n/a n/a
360° View
360° View
89 96 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
76 43 n/a n/a
Opinions Change
21 86 n/a n/a
Pro Holdings
n/a 94 n/a n/a
Market Pulse
57 79 n/a n/a
Sentiment
78 98 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
69 67 n/a n/a
Growth
82 63 n/a n/a
Safety Safety
42 70 n/a n/a
Combined
86 86 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
66 57 n/a n/a
Price vs. Earnings (P/E)
24 28 n/a n/a
Price vs. Book (P/B)
15 16 n/a n/a
Dividend Yield
92 98 n/a n/a
Value
69 67 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
26 26 n/a n/a
Profit Growth
83 84 n/a n/a
Capital Growth
82 33 n/a n/a
Stock Returns
80 83 n/a n/a
Growth
82 63 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
26 64 n/a n/a
Refinancing
14 24 n/a n/a
Liquidity
86 89 n/a n/a
Safety Safety
42 70 n/a n/a

Similar Stocks

Discover high‑ranked alternatives to Gilead and broaden your portfolio horizons.

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

PriceSmart

NasdaqGS:PSMT
Country: USA
Industry: Hypermarkets, Super Centers
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.